Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Sanofi
Sanofi
Sanofi opens doors to $130M 'flagship' US office facility in New Jersey
Fierce Pharma
Thu, 05/22/25 - 09:22 pm
Sanofi
New Jersey
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Fierce Biotech
Thu, 05/22/25 - 11:42 am
Sanofi
M&A
Vigil Neuroscience
Alzheimer's disease
Zentiva inks €220M deal to commercialize AstraZeneca GI cast-off in Europe
Fierce Pharma
Thu, 05/22/25 - 11:10 am
Sanofi
Zentiva
AstraZeneca
Europe
linaprazan glurate
Sanofi hops on the US investment bandwagon with $20B commitment through 2030
Fierce Pharma
Wed, 05/14/25 - 10:52 pm
Sanofi
drug manufacturing
Sanofi axes IGM pact, sparking 80% layoffs at the biotech and facility closures
Fierce Biotech
Fri, 05/9/25 - 08:28 am
Sanofi
IGM Biosciences
layoffs
Sanofi exec tells biotechs not to scrimp on clinical trial design
Clinical Trials Arena
Thu, 05/8/25 - 10:47 pm
Sanofi
biotech
clinical trials
clinical trial design
Sanofi nets €10B from Opella stake sale, eyes more 'bolt-on' deals
Fierce Pharma
Wed, 04/30/25 - 11:47 pm
Sanofi
consumer health
Opella
M&A
Sanofi's quarterly profit boosted by Dupixent and newer drugs; forecast unchanged
MSN Reuters
Thu, 04/24/25 - 11:01 am
Sanofi
earnings
Dupixent
Sanofi hands back cancer NK cell engager to Innate amid autoimmune pivot
Fierce Biotech
Wed, 04/23/25 - 09:47 am
Sanofi
natural killer cells
Innate Pharma
Sanofi, Regeneron win FDA nod for Dupixent in chronic hives
BioPharma Dive
Mon, 04/21/25 - 11:13 am
Sanofi
Regeneron
Dupixent
FDA
chronic hives
Sanofi pens $1.8B research deal for 2 bispecific antibodies aimed at autoimmune, immunology
Fierce Biotech
Thu, 04/17/25 - 11:08 am
Sanofi
Earendil Labs
bispecific antibodies
ulcerative colitis
Crohn’s disease
Sanofi's 'daughter of Dupixent' heads to phase 3 in asthma
Pharmaphorum
Tue, 04/15/25 - 09:53 am
Sanofi
Dupixent
clinical trials
asthma
amlitelimab
AAN 2025: Sanofi’s tolebrutinib likely to be first BTK inhibitor for the treatment of MS
Clinical Trials Arena
Wed, 04/9/25 - 10:58 pm
AAN
Sanofi
tolebrutinib
MS
multiple sclerosis
The top 10 pharma R&D budgets for 2024
Fierce Biotech
Fri, 04/4/25 - 11:30 am
R&D
Merck
JNJ
Roche
AstraZeneca
AbbVie
Bristol Myers Squibb
Eli Lilly
Pfizer
Novartis
Sanofi
Sanofi taps Nurix for pipeline nourishment once again, picking up autoimmune degrader for $15M
Fierce Biotech
Wed, 04/2/25 - 11:40 am
Sanofi
Nurix Therapeutics
autoimmune diseases
protein degradation
FDA approves first-of-its-kind RNA drug for hemophilia
BioPharma Dive
Sun, 03/30/25 - 10:26 pm
Sanofi
FDA
fitusiran
Qfitlia
hemophilia
FDA fast-tracks Sanofi's experimental chlamydia vaccine
Pharmaphorum
Thu, 03/27/25 - 11:05 am
Sanofi
vaccines
chlamydia
FDA
FDA starts review of Sanofi's MS hope tolebrutinib
Pharmaphorum
Tue, 03/25/25 - 10:20 am
Sanofi
FDA
tolebrutinib
MS
multiple sclerosis
Sanofi to acquire Dren Bio’s immunology unit
Investing.com
Thu, 03/20/25 - 11:25 am
Sanofi
Dren Bio
immunology
DR-0201
M&A
autoimmune diseases
Lilly, J&J, Pfizer and Sanofi back Teva fight against IRA drug negotiation program
Fierce Pharma
Tue, 03/18/25 - 11:00 pm
Teva Pharmaceutical
JNJ
Eli Lilly
Pfizer
Sanofi
legal
Inflation Reduction Act
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »